← Back to Clinical Trials
Recruiting NCT07244146

NCT07244146 Effects of CHRIST Among Children With Spastic CP

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07244146
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 14 participants
Start Date 2025-10-22
Primary Completion 2026-06-02

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
CHRIST

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 14 participants in total. It began in 2025-10-22 with a primary completion date of 2026-06-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This Quasi experimental study investigates the effects of CHRIST on In Hand Manipulation and Grip Strength amonfg children with Spastic Cerebral Palsy. The study involves 14 children from 6-12 years of age, and will be given intervention for 10 weeks period. Key performance outcomes- In Hand Manipulation and Grip Strength will be assessed both before and after the intervention. This study aims to address this gap by evaluating the effects of the CHRIST on IHM and grip strength in children diagnosed with spastic cerebral palsy. The hypothesis is that integrating strength training with high repetition, functionally relevant tasks yields greater and more practical gains than strength training or conventional therapy alone. Data will be analyzed through SPSS version 27.0

Eligibility Criteria

Inclusion Criteria: * Children Diagnosed with hemiplegic spastic cerebral palsy. * Age 6-12 years. * Capable of following commands regarding hand use and testing. * Capable of communicating needs. * Parents or caregivers willing to provide informed consent and participate in the study. * No contraindications to moderate physical activity. * Able to lift the more affected arm 15 cm above a table surface and grasp light objects Exclusion Criteria: * Children with musculoskeletal system injuries, including upper limb fractures or contractures, as well as those who had received medications affecting muscle strength or spasticity, were excluded from the study. * Orthopedic surgery involving the more affected hand within the past 6 months. * Children with Cardiovascular disease. * Lack of cooperation with instructions or other behavioral challenges that prevent effective delivery of intensive therapy. * Visual impairments that may hinder active participation. * Seizure or family history of seizure disorders

Contact & Investigator

Central Contact

IMRAN AMJAD, PHD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

FAIRY ALI, MSPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07244146 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07244146 currently recruiting?

Yes, NCT07244146 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07244146 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07244146 clinical trial?

NCT07244146 is sponsored by Riphah International University. The principal investigator is FAIRY ALI, MSPT at Riphah International University. The trial plans to enroll 14 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology